No takes yet. Share an insight, caveat, or question.
This review examines advancements in methods for genetic toxicity assessment in pharmaceuticals and medical devices, suggesting their regulatory acceptance may enhance safety testing.
Lynn M. Crosby (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: